- Oral presentation
- Open Access
Regulation of immune cell responses by semaphorins and their receptors
Arthritis Research & Therapy volume 14, Article number: O45 (2012)
Semaphorins were originally identified as axon guidance factors involved in the development of the neuronal system. However, accumulating evidence indicates that several members of semaphorins, so-called 'immune semaphorins', are crucially involved in various phases of immune responses (Figure 1) [1–3]. In addition, semaphorins and their receptors have been shown to be crucial for the pathogenesis of immunological disorders such as atopic dermatitis, multiple sclerosis, systemic sclerosis, systemic lupus erythematosus and rheumatoid arthritis, These semaphorins regulate immune cell interactions during physiological and pathological immune responses. However, conventional static analysis could not determine definitively whether they regulate immune cell movement.
Materials and methods
Plexin-A1-/- mice were previously established . Combinational studies, including imaging technique for visualizing single-cell dynamics and conventional immunological assays were performed.
Results and discussion
We find that plexin-A1-mediated semaphorin signals are crucially involved in the transmigration of DCs across the lymphatics to exit the periphery to induce antigen-specific T-cell priming using plexin-A1-/- mice. In addition, adoptive transfer experiments identify that Sema3A produced in the lymphatics functions as a ligand for the plexin-A1/NP-1 receptor complex expressed in DCs. Interestingly, plexin-A1 is localized at the trailing edge but not the leading edge of DCs during migration. Sema3A induces phosphorylation of the myosin light chain to promote actomyosin contraction, resulting in increased DC velocity in the constricted area (Figure 2). Collectively, these findings not only demonstrate the involvement of semaphorins in immune cell trafficking but also indicate that semaphorins are therapeutic targets to treat immunological disorders.
Suzuki K, et al: Semaphorin 7A initiates T-cell-mediated inflammatory responses through alpha1beta1 integrin. Nature. 2007, 446: 680-684. 10.1038/nature05652.
Suzuki K, et al: Semaphorins and their receptors in immune cell interactions. Nat Immunol. 2008, 9: 17-23. 10.1038/ni1553.
Nogi T, et al: Structural basis for semaphorin signalling through the plexin receptor. Nature. 2010, 467: 1123-7. 10.1038/nature09473.
Takegahara N, et al: Plexin-A1 and its interaction with DAP12 in immune responses and bone homeostasis. Nat Cell Biol. 2006, 8: 615-622. 10.1038/ncb1416.
Takamatsu H, et al: Semaphorins guide the entry of dendritic cells into the lymphatics by activating myosin II. Nat Immunol. 2010, 11: 594-600.
Rights and permissions
This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Kumanogoh, A., Takamatsu, H. Regulation of immune cell responses by semaphorins and their receptors. Arthritis Res Ther 14 (Suppl 1), O45 (2012). https://doi.org/10.1186/ar3600
- Multiple Sclerosis
- Systemic Lupus Erythematosus
- Atopic Dermatitis
- Myosin Light Chain
- Immunological Disorder